Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antti Arjonen

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
BMC Cancer|June 25, 2020
Ex vivo modelling of drug efficacy in a rare metastatic urachal carcinomaRami Mäkelä, Antti Arjonen, Ville Härmä, et al.
Neoplasia (New York, N.Y.)|July 10, 2020
Ex vivo assessment of targeted therapies in a rare metastatic epithelial-myoepithelial carcinomaRami Mäkelä, Antti Arjonen, Aldwin Suryo Rahmanto, et al.
Frontiers in Oncology|October 4, 2021
<i>Ex Vivo</i> Drug Screening Informed Targeted Therapy for Metastatic Parotid Squamous Cell CarcinomaNoora Nykänen, Rami Mäkelä, Antti Arjonen, et al.
Developmental Cell|August 11, 2015
Formin-like 2 Promotes β1-Integrin Trafficking and Invasive Motility Downstream of PKCαYing Wang, Antti Arjonen, Jeroen Pouwels, et al.
Nature Structural & Molecular Biology|January 19, 2016
Selective integrin endocytosis is driven by interactions between the integrin α-chain and AP2Nicola De Franceschi, Antti Arjonen, Nadia Elkhatib, et al.
Journal of Cell Science|March 25, 2014
An RNAi screen identifies KIF15 as a novel regulator of the endocytic trafficking of integrinAnastasia Eskova, Bettina Knapp, Dorota Matelska, et al.
Developmental Cell|September 23, 2008
Integrin trafficking regulated by Rab21 is necessary for cytokinesisTeijo Pellinen, Saara Tuomi, Antti Arjonen, et al.
The Journal of Clinical Investigation|February 4, 2014
Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasisAntti Arjonen, Riina Kaukonen, Elina Mattila, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
BMC Cancer|June 25, 2020
Ex vivo modelling of drug efficacy in a rare metastatic urachal carcinomaRami Mäkelä, Antti Arjonen, Ville Härmä, et al.
Neoplasia (New York, N.Y.)|July 10, 2020
Ex vivo assessment of targeted therapies in a rare metastatic epithelial-myoepithelial carcinomaRami Mäkelä, Antti Arjonen, Aldwin Suryo Rahmanto, et al.
Frontiers in Oncology|October 4, 2021
<i>Ex Vivo</i> Drug Screening Informed Targeted Therapy for Metastatic Parotid Squamous Cell CarcinomaNoora Nykänen, Rami Mäkelä, Antti Arjonen, et al.
Developmental Cell|August 11, 2015
Formin-like 2 Promotes β1-Integrin Trafficking and Invasive Motility Downstream of PKCαYing Wang, Antti Arjonen, Jeroen Pouwels, et al.
Nature Structural & Molecular Biology|January 19, 2016
Selective integrin endocytosis is driven by interactions between the integrin α-chain and AP2Nicola De Franceschi, Antti Arjonen, Nadia Elkhatib, et al.
Journal of Cell Science|March 25, 2014
An RNAi screen identifies KIF15 as a novel regulator of the endocytic trafficking of integrinAnastasia Eskova, Bettina Knapp, Dorota Matelska, et al.
Developmental Cell|September 23, 2008
Integrin trafficking regulated by Rab21 is necessary for cytokinesisTeijo Pellinen, Saara Tuomi, Antti Arjonen, et al.
The Journal of Clinical Investigation|February 4, 2014
Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasisAntti Arjonen, Riina Kaukonen, Elina Mattila, et al.
Pageof 2